 |
Epoetin alpha |
|---|---|
| Trade Name | Procrit |
| Orphan Indication | Anemia associated with end stage renal disease |
| USA Market Approval | USA |
| USA Designation Date | 1987-08-27 00:00:00 |
| Sponsor | R. W. Johnson Pharmaceutical Research Institute;Route 202 South, P.O. Box 300;Raritan, New Jersey, 08869 |
